XML 52 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2020
Federal Home Loan Banks [Abstract]  
Summary of Preferred Stock Allocated to Investors The Purchase Agreement provides for the Company to issue and sell to the Investor shares of the Company’s preferred stock in the amounts set forth in the following table (numbers have been adjusted for the February 2016 reverse stock split):
 
Convertible
Preferred Stock
  
Shares
   
Price Per Share
   
Total
Investment
 
Series
 
AA-1
   8,427,004  $12.00   $101,124,048
Series
 
AA-2
   7,223,145  $6.00    43,338,870
  
 
 
     
 
 
 
   15,650,149    $144,462,918
  
 
 
     
 
 
 
Summary of Stock Option Activity
Additional information with respect to both plans stock option activity is as follows:
 
   
Number of
Shares
   
Weighted Average
Exercise Price
 
Outstanding at December 31, 2017
   247,817   $16.76 
Granted
   —     $—   
Exercised
   —     $—   
Cancelled
   (9,166  $36.52 
  
 
 
   
 
 
 
Outstanding at December 31, 2018
   238,651   $15.95 
Granted
   —     $—   
Exercised
   —     $—   
Cancelled
   —     $—   
  
 
 
   
 
 
 
Outstanding at December 31, 2019
   238,651   $15.95 
Granted
   —     $—   
Exercised
   —     $—   
Cancelled
   —     $—   
  
 
 
   
 
 
 
Outstanding at December 31, 2020
   238,651   $15.95 
  
 
 
   
 
 
 
Options exercisable at December 31, 2018
   238,651   $15.95 
  
 
 
   
 
 
 
Options exercisable at December 31, 2019
   238,651   $15.95 
  
 
 
   
 
 
 
Options exercisable at December 31, 2020
   238,651   $15.95 
  
 
 
   
 
 
 
Stock Options Outstanding
The following table summarizes information about stock options outstanding at December 31, 2020:
 
Stock Options Outstanding
Range of Exercise
Prices
  
Number of Shares
Outstanding
  
Weighted Average
Remaining Contractual
Life in Years
  
Weighted Average Exercise
Price
$26.40 -$26.40
  75,158  3.00  $26.40
$12.48 - $12.84
  141,000  4.00  $12.48
$2.02 - $3.59
  22,493  5.65  $2.74
 
  
 
  
 
  
 
  238,651  3.84  $15.95
  
 
  
 
  
 
Estimated Fair Value of Restricted Stock Award
The estimated fair value of each restricted stock award is calculated using the share price at the date of the grant. A summary of the status of the restricted stock awards as of December 31, 2020 and changes during the year ended December 31, 2020 is presented as follows:
 
   
Number of
Shares
   
Weighted Average
Grant Date Fair
Value
 
Unvested at December 31, 2019
   41,667   $11.04 
Granted
   366,126   $4.00 
Vested
   (158,402  $4.00 
Cancelled
      $ 
  
 
 
   
 
 
 
Unvested at December 31, 2020
   249,391   $5.18 
  
 
 
   
 
 
 
Summary of Common Stock Warrants Outstanding
The following table summarizes our common stock warrants outstanding at December 31, 2020:
 
Common Stock Warrants
  
Exercise Price
  
Termination Date
196,135  $5.76  07/08/2024
700,000  $7.16  11/02/2023
551,378  $3.99  **
131,816  $4.67  08/14/2023
1,901,985  $4.75  02/25/2024
 
    
3,481,314    
 
    
**
A five-year term commences upon the earliest occurrence of either Trigger Date A or Trigger Date B. Trigger Date A is the date on which the Claimholder ceases the Subject Claim for any reason other than (i) a full and final arbitral award against the Claimholder or (ii) a full and final monetary settlement of the claim, see NOTE H – Note 9 – Litigation financing.
 
Summary of Analysis of Activity in CARs Balances
The following is an analysis of activity in the CARs balances as of December 31, 2020:
 
   
Number of CARs
 
   
Key Employee
Plan
   
Nonemployee
Director Plan
 
Unvested at December 31, 2019
   135,701    —   
Granted
   —      —   
Vested
   (135,701   —   
Cancelled
   —      —   
  
 
 
   
 
 
 
Unvested at December 31, 2020
   —      —